Respiratory resistance (Rrs5 and Rrs20) and reactance (Xrs5) and pulmonary function tests were measured by MostGraph-02 (Chest M I, Co Ltd, Tokyo, Japan) in 200 normal subjects and 150 stable COPD patients.